Cancer Treatment using Specified Products
Dear South Eastern Health and Social Care Trust (Northern Ireland),
1) In the past 6 months, what was the number of patients treated with a combination of Dabrafenib + Trametinib for the following conditions:
A) Metastatic Melanoma
B) Adjuvant Melanoma
C) BRAF mutated Lung Cancer
2) In the past 6 months, what was the number of patients treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following conditions:
A) Metastatic Melanoma
B) Colorectal Cancer
Yours faithfully,
BEN HOLDSWORTH
Thank you for your email which has been received by the Information
Governance Department, South Eastern Health and Social Care Trust.
We will respond to your email as soon as possible, we aim to reply to you
within the statutory time frames.
Please note our office hours are Monday to Friday 9-5 excluding Bank and
Public holidays, outside of these hours your email will not be actioned
until the next working day.
Information Governance Department
The information contained in this email and any attachments is
confidential and intended solely for the attention and use of the named
addressee(s). No confidentiality or privilege is waived or lost by any
mistransmission. If you are not the intended recipient of this email,
please inform the sender by return email and destroy all copies. Any views
or opinions presented are solely those of the author and do not
necessarily represent the views of HSC. The content of emails sent and
received via the HSC network may be monitored for the purposes of ensuring
compliance with HSC policies and procedures. Please be aware that e-mail
may not be a secure medium. This e-mail (whether you are the sender or the
recipient) may be monitored and monitoring and blocking software may be
used. While HSC takes precautions in scanning outgoing emails for computer
viruses, no responsibility will be accepted by HSC in the event that the
email is infected by a computer virus. Recipients are therefore encouraged
to take their own precautions in relation to virus scanning. All emails
held by HSC may be subject to public disclosure under the Freedom of
Information Act 2000. All emails held by HSC may also be disclosed, where
required, under the UK GDPR and Data Protection Act 2018.
Dear Ben
Freedom of Information Act 2000 – Information in relation to cancer
patients
Thank you for your correspondence regarding the above. Your request was
received on 12/06/2024 and I am dealing with it under the terms of the
above legislation.
If you have any queries, please do not hesitate to contact me quoting the
reference number above.
Kind regards
Irene Stewart
Obo Rebecca Manning
Information Governance Officer
Information Governance Team
Lough House, Ards Community Hospital
02891512021
The information contained in this email and any attachments is
confidential and intended solely for the attention and use of the named
addressee(s). No confidentiality or privilege is waived or lost by any
mistransmission. If you are not the intended recipient of this email,
please inform the sender by return email and destroy all copies. Any views
or opinions presented are solely those of the author and do not
necessarily represent the views of HSC. The content of emails sent and
received via the HSC network may be monitored for the purposes of ensuring
compliance with HSC policies and procedures. Please be aware that e-mail
may not be a secure medium. This e-mail (whether you are the sender or the
recipient) may be monitored and monitoring and blocking software may be
used. While HSC takes precautions in scanning outgoing emails for computer
viruses, no responsibility will be accepted by HSC in the event that the
email is infected by a computer virus. Recipients are therefore encouraged
to take their own precautions in relation to virus scanning. All emails
held by HSC may be subject to public disclosure under the Freedom of
Information Act 2000. All emails held by HSC may also be disclosed, where
required, under the UK GDPR and Data Protection Act 2018.
Dear Mr Holdsworth,
Please see attached response from the South Eastern H&SC Trust in relation
to your request for information received on 12 June 2024.
Kind regards
Rebecca Manning
Information Governance Team
Email:- [1][email address]
The information contained in this email and any attachments is
confidential and intended solely for the attention and use of the named
addressee(s). No confidentiality or privilege is waived or lost by any
mistransmission. If you are not the intended recipient of this email,
please inform the sender by return email and destroy all copies. Any views
or opinions presented are solely those of the author and do not
necessarily represent the views of HSC. The content of emails sent and
received via the HSC network may be monitored for the purposes of ensuring
compliance with HSC policies and procedures. Please be aware that e-mail
may not be a secure medium. This e-mail (whether you are the sender or the
recipient) may be monitored and monitoring and blocking software may be
used. While HSC takes precautions in scanning outgoing emails for computer
viruses, no responsibility will be accepted by HSC in the event that the
email is infected by a computer virus. Recipients are therefore encouraged
to take their own precautions in relation to virus scanning. All emails
held by HSC may be subject to public disclosure under the Freedom of
Information Act 2000. All emails held by HSC may also be disclosed, where
required, under the UK GDPR and Data Protection Act 2018.
References
Visible links
1. mailto:[email address]
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now